Drug interactions for the following drug(s)
Applies to: Fenofibrate 160 MG Oral Tablet <> Fenofibrate 160 MG Oral Tablet
The risk or severity of adverse effects can be increased when Fenofibrate is combined with Fenofibric acid.
Applies to: Fenofibrate 160 MG Oral Tablet <> CRESTOR 10 MG Oral Tablet
The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibric acid is combined with Rosuvastatin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Fenofibrate 160 MG Oral Tablet <> Fenofibrate 160 MG Oral Tablet
Drug1 (rxcui = 349287, name = Fenofibrate 160 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 349287, name = Fenofibrate 160 MG Oral Tablet, tty = SCD). Drug1 is resolved to Fenofibrate, Drug2 is resolved to fenofibric acid and interaction asserted in DrugBank between Fenofibrate and Fenofibric acid. Drug1 is resolved to fenofibric acid, Drug2 is resolved to Fenofibrate and interaction asserted in DrugBank between Fenofibric acid and Fenofibrate.
Applies to: Fenofibrate 160 MG Oral Tablet <> CRESTOR 10 MG Oral Tablet
Drug1 (rxcui = 349287, name = Fenofibrate 160 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 859749, name = Rosuvastatin calcium 10 MG Oral Tablet [Crestor], tty = SBD). Drug1 is resolved to fenofibric acid, Drug2 is resolved to rosuvastatin and interaction asserted in DrugBank between Fenofibric acid and Rosuvastatin. Drug1 is resolved to Fenofibrate, Drug2 is resolved to rosuvastatin and interaction asserted in DrugBank between Fenofibrate and Rosuvastatin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.